BNP (B-TYPE NATRIURETIC PEPTIDE)

BNP Consensus Panel 2004: A Clinical Approach for the Diagnosis, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases.
Congestive Heart Failure, September-October 2004, Supp 3.
(Most recent comprehensive article up to 2004, 27 pages, not available on WWW.)

(This top section was prepared in 2002)

• Levin ER, Gardner DG, Samson WK.
  Natriuretic peptides.
  N Engl J Med. 1998 Jul 30;339(5):321-8. Review. (Physiology)
• Colucci WS.
  Nesiritide for the treatment of decompensated heart failure.
  J Card Fail. 2001 Mar;7(1):92-100. Review. (General)
• Maisel A.
  B-type natriuretic peptide in the diagnosis and management of congestive heart failure.
  Cardiol Clin. 2001 Nov;19(4):557-71. Review. (General)
• Peacock WF 4th.
  The B-type natriuretic peptide assay: a rapid test for heart failure.
  Cleve Clin J Med. 2002 Mar;69(3):243-51. Review. (General)
• Mills RM, Hobbs RE.
  How to use nesiritide in treating decompensated heart failure.
  Cleve Clin J Med. 2002 Mar;69(3):252-6. Review. (General)
• Nicholls MG, Lainchbury JG, Richards AM, Troughton RW, Yandle TG.
  Brain natriuretic peptide-guided therapy for heart failure.
  Ann Med. 2001 Sep;33(6):422-7. (General)
• Maisel A.
  B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure.
  J Card Fail. 2001 Jun;7(2):183-93. Review. (Diagnosis)
• Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A.
  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
  J Am Coll Cardiol. 2002 Jan 16;39(2):202-9. (Diagnosis)
• Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS.
  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.
  J Am Coll Cardiol. 2001 Feb;37(2):379-85. (Diagnosis)
• Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS.
  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
  Ann Emerg Med. 2002 Feb;39(2):131-8. (Diagnosis)
• Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A.
  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.
  J Am Coll Cardiol. 2001 Feb;37(2):386-91. (Prognosis)
• Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A.
  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
  J Card Fail. 2001 Mar;7(1):21-9. (Treatment)
• Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).
  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. (VMAC)
  JAMA. 2002 Mar 27;287(12):1531-40. (Trial)
• Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM.
  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
  Lancet. 2000 Apr 1;355(9210):1126-30. (Follow up)
  
  

2002

• Bettencourt P.
  Brain natriuretic peptide (nesiritide) in the treatment of heart failure.
  Cardiovasc Drug Rev. 2002 Winter;20(1):27-36. Review
• Cowie MR, Mendez GF.
  BNP and congestive heart failure.
  Prog Cardiovasc Dis. 2002 Jan-Feb;44(4):293-321. Review.
• Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A.
  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
  J Am Coll Cardiol. 2002 Jan 16;39(2):202-9.
• Ogawa K, Oida A, Sugimura H, Kaneko N, Nogi N, Hasumi M, Numao T, Nagao I, Mori S.
  Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: comparison of electrocardiography, chest radiography and echocardiography.
  Circ J. 2002 Feb;66(2):122-6.
• Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS.
  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
  Ann Emerg Med. 2002 Feb;39(2):131-8.
• Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS.
  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.
  Circulation. 2002 Feb 5;105(5):595-601. Erratum in: Circulation 2002 Jul 16;106(3):387.
• Lee CR, Adams KF Jr, Patterson JH.
  Surrogate end points in heart failure.
  Ann Pharmacother. 2002 Mar;36(3):479-88. Review.
• Mills RM, Hobbs RE.
  How to use nesiritide in treating decompensated heart failure.
  Cleve Clin J Med. 2002 Mar;69(3):252-6. Review.
• Peacock WF 4th.
  The B-type natriuretic peptide assay: a rapid test for heart failure.
  Cleve Clin J Med. 2002 Mar;69(3):243-51. Review.
• [No authors listed]
  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. (VMAC)
  JAMA. 2002 Mar 27;287(12):1531-40.
• Silver MA, Horton DP, Ghali JK, Elkayam U.
  Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
  J Am Coll Cardiol. 2002 Mar 6;39(5):798-803.
• Schreiner GF, Protter AA.
  B-type natriuretic peptide for the treatment of congestive heart failure.
  Curr Opin Pharmacol. 2002 Apr;2(2):142-7. Review.
• Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW.
  Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.
  J Am Coll Cardiol. 2002 May 15;39(10):1623-9.
• Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R.
  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
  Circulation. 2002 May 21;105(20):2392-7.
• Richards AM, Lainchbury JG, Nicholls MG, Troughton RW, Yandle TG.
  BNP in hormone-guided treatment of heart failure.
  Trends Endocrinol Metab. 2002 May-Jun;13(4):151-5. Review.
• Maisel A.
  B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?
  Circulation. 2002 May 21;105(20):2328-31.
• Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, Redfield MM, Burnett JC Jr.
  The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
  J Card Fail. 2002 Jun;8(3):149-54.
• Elkayam U, Akhter MW, Tummala P, Khan S, Singh H.
  Nesiritide: a new drug for the treatment of decompensated heart failure.
  J Cardiovasc Pharmacol Ther. 2002 Jul;7(3):181-94.
• Tabbibizar R, Maisel A.
  The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure.
  Curr Opin Cardiol. 2002 Jul;17(4):340-5.
• McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS.
  B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.
  Circulation. 2002 Jul 23;106(4):416-22.
• Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA.
  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
  N Engl J Med. 2002 Jul 18;347(3):161-7.
• Bettencourt P, Ferreira S, Azevedo A, Ferreira A.
  Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure.
  Am J Med. 2002 Aug 15;113(3):215-9.
• Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U.
  brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure.
  J Am Coll Cardiol. 2002 Aug 21;40(4):718-22.
• McGeoch G, Lainchbury J, Town G, Toop L, Espiner E, Richards A.
  Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice.
  Eur J Heart Fail. 2002 Aug;4(4):479.
• Daly C, Fox K, Henein M.
  Natriuretic peptides in the diagnosis of heart disease-First amongst equals?
  Int J Cardiol. 2002 Aug;84(2-3):107-13.
• Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, Zanker C, Bouvier E, Solal AC.
  Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.
  J Am Coll Cardiol. 2002 Nov 20;40(10):1794-800.
• Wieczorek SJ, Wu AH, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T, Hager D, Gardetto N, Chiu A, Bailly KR, Maisel A.
  A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.
  Am Heart J. 2002 Nov;144(5):834-9.
• Tjeerdsma G, de Boer RA, Boomsma F, van den Berg MP, Pinto YM, van Veldhuisen DJ.
  Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.
  Int J Cardiol. 2002 Dec;86(2-3):143-9; discussion 149-52.
• Kuster GM, Tanner H, Printzen G, Suter TM, Mohacsi P, Hess OM.
  B-type natriuretic peptide for diagnosis and treatment of congestive heart failure.
  Swiss Med Wkly. 2002 Dec 14;132(43-44):623-8. 10:
• Maisel A.
  B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient.
  Rev Cardiovasc Med. 2002;3 Suppl 4:S10-7. Review.
• A. Colli, M. Fraquelli, D. Conte, Y. Hassan, A. R. Shapira, S. Hassan, R. S. Foote, J. D. Pearlman, A. S. Maisel, P. Clopton, and P. A. McCullough
  B-Type Natriuretic Peptide in Heart Failure
  N. Engl. J. Med., December 12, 2002; 347(24): 1976 - 1978.

2003

• E. Lader
  B type natriuretic peptide levels had high sensitivity but moderate specificity for detecting CHF in the emergency department
  Evid. Based Med., January 1, 2003; 8(1): 28 - 28.
• McLean AS, Tang B, Nalos M, Huang SJ, Stewart DE.
  Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients.
  Anaesth Intensive Care. 2003 Feb;31(1):21-7.
• Wieczorek SJ, Hager D, Barry MB, Kearney L, Ferrier A, Wu AH.
  Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction.
  Clin Chim Acta. 2003 Feb;328(1-2):87-90.
• McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; Breathing Not Properly Multinational Study Investigators.
  B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
  Am J Kidney Dis. 2003 Mar;41(3):571-9.
• McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, McCord J, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; BNP Multinational Study Investigators.
  Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.
  Acad Emerg Med. 2003 Mar;10(3):198-204.
• P. A. McCullough, J. E. Hollander, R. M. Nowak, A. B. Storrow, P. Duc, T. Omland, J. McCord, H. C. Herrmann, P. G. Steg, A. Westheim, C. W. Knudsen, W. T. Abraham, S. Lamba, A. H.B. Wu, A. Perez, P. Clopton, P. Krishnaswamy, R. Kazanegra, and A. S. Maisel
  Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department
  Acad. Emerg. Med., March 1, 2003; 10(3): 198 - 204.
• McCullough PA.
  B-type natriuretic peptides. A diagnostic breakthrough in heart failure.
  Minerva Cardioangiol. 2003 Apr;51(2):121-9. Review.
• Bhatia V, Nayyar P, Dhindsa S.
  Brain natriuretic peptide in diagnosis and treatment of heart failure.
  J Postgrad Med. 2003 Apr-Jun;49(2):182-5. Review.
• McCullough PA, Omland T, Maisel AS.
  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
  Rev Cardiovasc Med. 2003 Spring;4(2):72-80. Review.
• Kucher N, Printzen G, Goldhaber SZ.
  Prognostic role of brain natriuretic peptide in acute pulmonary embolism.
  Circulation. 2003 May 27;107(20):2545-7. Epub 2003 May 12.
• Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, Omland T, Storrow AB, Krishnaswamy P, Abraham WT, Clopton P, Steg G, Aumont MC, Westheim A, Knudsen CW, Perez A, Kamin R, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators.
  Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
  J Am Coll Cardiol. 2003 Jun 4;41(11):2010-7.
• U. Hanusch-Enserer, K. M. Hermann, E. Cauza, M. Spak, B. Mahr, A. Dunky, H. R. Rosen, U. Koller, and R. Prager
  Effect of Gastric Banding on Aminoterminal Pro-brain Natriuretic Peptide in the Morbidly Obese
  Obes. Res., June 1, 2003; 11(6): 695 - 698.
• H. Ruskoaho
  Cardiac Hormones as Diagnostic Tools in Heart Failure
  Endocr. Rev., June 1, 2003; 24(3): 341 - 356.
• Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM.
  Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.
  J Am Coll Cardiol. 2003 Aug 20;42(4):728-35.
• Cardarelli R, Lumicao TG Jr.
  B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians.
  J Am Board Fam Pract. 2003 Jul-Aug;16(4):327-33. Review.
• Hainaut C, Gade W.
  The emerging roles of BNP and accelerated cardiac protocols in emergency laboratory medicine.
  Clin Lab Sci. 2003 Summer;16(3):166-79. Review.
• Catuzzo B, Ciancamerla F, Bobbio M, Longo M, Trevi GP.
  In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
  J Card Fail. 2003 Aug;9(4):303-10.
• McCullough PA, Sandberg KR.
  B-type natriuretic peptide and renal disease.
  Heart Fail Rev. 2003 Oct;8(4):355-8. Review.
• P. Pruszczyk, M. Kostrubiec, A. Bochowicz, G. Styczynski, M. Szulc, M. Kurzyna, A. Fijalkowska, A. Kuch-Wocial, I. Chlewicka, and A. Torbicki
  N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
  Eur. Respir. J., October 1, 2003; 22(4): 649 - 653.
• P. Pruszczyk, M. Kostrubiec, A. Bochowicz, G. Styczynski, M. Szulc, M. Kurzyna, A. Fijalkowska, A. Kuch-Wocial, I. Chlewicka, and A. Torbicki
  N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
  Eur. Respir. J., October 1, 2003; 22(4): 649 - 653.
• Maisel AS.
  The diagnosis of acute congestive heart failure: role of BNP measurements.
  Heart Fail Rev. 2003 Oct;8(4):327-34. Review.
• Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS.
  Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.
  Circulation. 2003 Dec 16;108(24):2964-6. Epub 2003 Dec 08.
• Safley DM, McCullough PA.
  The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients.
  Heart Fail Monit. 2003;4(1):13-20. Review.
• Maisel AS, McCullough PA.
  Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management.
  Rev Cardiovasc Med. 2003;4 Suppl 4:S3-12. Review.

2004

• Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg G, Westheim A, Knudsen CW, Perez A, Kazanegra R, Bhalla V, Herrmann HC, Aumont MC, McCullough PA; BNP Multinational Study Investigators.
  Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.
  Am Heart J. 2004 Jun;147(6):1078-84.
• Knudsen CW, Riis JS, Finsen AV, Eikvar L, Muller C, Westheim A, Omland T.
  Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender.
  Eur J Heart Fail. 2004 Jan;6(1):55-62.
• Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investigators.
  Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
  J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33.
• Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, McCord J, Nowak RM, Aumont MC, Duc P, Hollander JE, Wu AH, McCullough PA, Maisel AS.
  Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea.
  Am J Med. 2004 Mar 15;116(6):363-8.
• Morimoto T, Hayashino Y, Shimbo T, Izumi T, Fukui T.
  Is B-type natriuretic peptide-guided heart failure management cost-effective?
  Int J Cardiol. 2004 Aug;96(2):177-81.
• Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, Cohn JN.
  Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy.
  Circulation. 2004 Mar 2;109(8):984-9. Epub 2004 Feb 16.
• Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC.
  Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
  J Am Coll Cardiol. 2004 Feb 18;43(4):635-41.
• Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF.
  Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure.
  Am J Cardiol. 2004 May 1;93(9):1130-5.
• Barcarse E, Kazanegra R, Chen A, Chiu A, Clopton P, Maisel A.
  Combination of B-type natriuretic Peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department.
  Congest Heart Fail. 2004 Jul-Aug;10(4):171-6.
• Kruger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, Janssens U.
  Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism.
  Am Heart J. 2004 Jan;147(1):60-5.
• Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.
  Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. (Cost effective)
  N Engl J Med. 2004 Feb 12;350(7):647-54.
• Sharp A, Mayet J.
  The utility of BNP in clinical practice.
  J Renin Angiotensin Aldosterone Syst. 2004 Jun;5(2):53-8.
• Dahlstrom U.
  Can natriuretic peptides be used for the diagnosis of diastolic heart failure?
  Eur J Heart Fail. 2004 Mar 15;6(3):281-7. Review.
• de Denus S, Pharand C, Williamson DR.
  Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.
  Chest. 2004 Feb;125(2):652-68. Review.
• BNP Consensus Panel 2004: A Clinical Approach for the Diagnosis, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases.
  Congestive Heart Failure, September-October 2004, Supp 3
• M. Kemp, J. Donovan, H. Higham, and J. Hooper
  Biochemical markers of myocardial injury
  Br. J. Anaesth., July 1, 2004; 93(1): 63 - 73.
• D. B. Mark and G. M. Felker
  B-Type Natriuretic Peptide -- A Biomarker for All Seasons?
  N. Engl. J. Med., February 12, 2004; 350(7): 718 - 720.
• A. Clerico and M. Emdin
  Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review
  Clin. Chem., January 1, 2004; 50(1): 33 - 50.
• P. Pruszczyk, M. Kostrubiec, A. Bochowicz, G. Styczynski, M. Szulc, M. Kurzyna, A. Fijalkowska, A. Kuch-Wocial, I. Chlewicka, and A. Torbicki
  N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
  Eur. Respir. J., October 1, 2003; 22(4): 649 - 653.
• U. Hanusch-Enserer, K. M. Hermann, E. Cauza, M. Spak, B. Mahr, A. Dunky, H. R. Rosen, U. Koller, and R. Prager
  Effect of Gastric Banding on Aminoterminal Pro-brain Natriuretic Peptide in the Morbidly Obese
  Obes. Res., June 1, 2003; 11(6): 695 - 698.
• H. Ruskoaho
  Cardiac Hormones as Diagnostic Tools in Heart Failure
  Endocr. Rev., June 1, 2003; 24(3): 341 - 356.
• P. A. McCullough, J. E. Hollander, R. M. Nowak, A. B. Storrow, P. Duc, T. Omland, J. McCord, H. C. Herrmann, P. G. Steg, A. Westheim, C. W. Knudsen, W. T. Abraham, S. Lamba, A. H.B. Wu, A. Perez, P. Clopton, P. Krishnaswamy, R. Kazanegra, and A. S. Maisel
  Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department
  Acad. Emerg. Med., March 1, 2003; 10(3): 198 - 204.
• E. Lader
  B type natriuretic peptide levels had high sensitivity but moderate specificity for detecting CHF in the emergency department
  Evid. Based Med., January 1, 2003; 8(1): 28 - 28.
• A. Clerico and M. Emdin
  Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review
  Clin. Chem., January 1, 2004; 50(1): 33 - 50.
• Yancy CW, Saltzberg MT, Berkowitz RL, Bertolet B, Vijayaraghavan K, Burnham K, Oren RM, Walker K, Horton DP, Silver MA.
  Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).
  Am J Cardiol. 2004 Sep 1;94(5):595-601.
• Yancy CW, Burnett JC, Fonarow GC, Silver MA,
  Decompensated Heart Failure: Is There a Role for the Outpatient Use of Nesiretide?
  Congestive Heart Failure. September-October 2004, Suppl 5
• H. G. Wahl, S. Graf, H. Renz, and W. Fassbinder
  Elimination of the Cardiac Natriuretic Peptides B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP by Hemodialysis
  Clin. Chem., June 1, 2004; 50(6): 1071 - 1074.

Back to top